Dalvance (dalbavancin) Patient Assistance Program
Don’t let the high cost of brand long-acting lipoglycopeptide antibiotic disrupt your skin infection treatment. We help eligible patients access Dalvance (dalbavancin IV) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Dalvance (dalbavancin) is FDA-approved for acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive organisms including MRSA. Second-generation lipoglycopeptide with a very long half-life enabling single-dose or two-dose IV regimens — avoiding daily IV or prolonged hospitalization.
- Without assistance, Dalvance costs commonly run approximately $3,000–$5,000 per full course.
- Through AffordMyPrescriptions, qualifying patients can access Dalvance for a flat $69.95 per month coverage.
- Similar long-acting lipoglycopeptide: oritavancin (Orbactiv/Kimyrsa — single-dose IV). Traditional MRSA options: vancomycin (generic — daily IV, monitoring), linezolid (Zyvox generic — oral/IV), daptomycin (Cubicin generic), ceftaroline (Teflaro), tedizolid (Sivextro), delafloxacin (Baxdela). For ABSSSI: incision and drainage often first-line for abscesses; oral options for outpatient (TMP-SMX generic, doxycycline generic, clindamycin generic, linezolid generic). Dalvance's advantage: single/two-dose IV enables ED-based treatment avoiding hospitalization or PICC line.
What is Dalvance Prescription Assistance Program?
The Dalvance Patient Assistance Program helps eligible patients access Dalvance for ABSSSI at little or no cost when meeting income, insurance, and clinical criteria. Free to apply but involves detailed applications, ED/hospital coordination, and documentation.
At AffordMyPrescriptions, our Patient Advocates handle the entire Dalvance PAP enrollment for a flat $69.95 per month — so you never face a gap in Dalvance therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Dalvance enrollment — so you never face a gap in your acute bacterial skin infection treatment.
Pharmacy Price Comparison
- Without assistance, Dalvance costs thousands of dollars per course. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic vancomycin (traditional) | ~$100/day IV | Traditional MRSA alt daily IV |
| Hospital pharmacy | ~$5,000/course | Save substantially |
| ED infusion | ~$4,500/course | Save substantially |
| Specialty pharmacy | ~$3,500/course | Save substantially |
| 340B-eligible institution | ~$3,000/course | Save substantially |
| Oritavancin (alt single-dose) | ~$3,000/dose | Alt long-acting lipoglycopeptide |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Dalvance — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Dalvance Prescription Program?
The Dalvance Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy: applications, prescriber coordination, ED/hospital administration, and re-enrollment. The single/two-dose regimen enables outpatient management and avoids hospitalization or a PICC line — a significant advantage for select patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Dalvance assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Dalvance is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Dalvance:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $3,000–$5,000/course even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Dalvance assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Dalvance Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Dalvance:
Dalvance is a second-generation lipoglycopeptide with a terminal half-life of ~14 days — enabling single-dose (1500 mg IV over 30 min) or two-dose (1000 mg then 500 mg one week later) regimens for ABSSSI. It uniquely allows ED-based IV antibiotic completion, avoiding hospitalization or PICC line placement.
How It Works:
Acute bacterial skin and skin structure infections (ABSSSI) — cellulitis, wound infections, major abscesses — are commonly caused by gram-positive organisms including MRSA. Treatment often requires IV antibiotics, historically necessitating hospitalization or outpatient IV via PICC line. Dalbavancin binds bacterial cell wall precursors (the D-Ala-D-Ala terminus), inhibiting transglycosylation and transpeptidation — bactericidal against gram-positive organisms including MRSA. A long lipophilic side chain anchors in the bacterial membrane, extending the half-life dramatically. A single or two-dose IV regimen delivers a complete course of therapy in the ED or clinic without hospitalization.
Form and Use:
Dalvance IV infusion. Single-dose regimen: 1500 mg IV over 30 min. Two-dose regimen: 1000 mg IV on day 1, 500 mg IV on day 8. Renal dose adjustment. Administered in ED, infusion center, or outpatient setting.
Generic Availability:
No generic Dalvance. Oritavancin (Orbactiv, Kimyrsa) is a similar single-dose IV lipoglycopeptide. Traditional MRSA IV options (all generic): vancomycin (daily IV, therapeutic drug monitoring, longer duration), daptomycin (Cubicin generic), linezolid (Zyvox generic — oral or IV, cheaper), telavancin (Vibativ — brand). Oral options for outpatient ABSSSI (all generic): TMP-SMX (Bactrim), doxycycline, clindamycin, linezolid, delafloxacin (Baxdela — brand), tedizolid (Sivextro — brand). For abscesses, incision and drainage (I&D) is often the primary intervention. Choice depends on severity, MRSA risk, patient factors, and outpatient feasibility.
Warnings:
Hypersensitivity reactions (including anaphylaxis — do not administer with history of severe reactions to glycopeptides), infusion-related reactions including ‘red man syndrome’ (slow infusion to prevent), C. difficile-associated diarrhea, hepatotoxicity (mild ALT elevations common — monitor with prolonged use). Other: nausea, headache, diarrhea. Renal dose adjustment. Drug interactions minimal. Pregnancy considerations.
FAQ (Frequently Asked Questions)
How much does Dalvance cost without insurance?
$3,000–$5,000 per full course. Total course cost is comparable to a hospital stay for daily IV vancomycin — but it avoids hospitalization/PICC and reduces total healthcare cost significantly.
What is the advantage of Dalvance's long half-life?
It enables a single-dose (1500 mg) or two-dose (1000 mg + 500 mg one week later) IV regimen — a complete ABSSSI antibiotic course delivered in the ED or clinic without hospitalization or a PICC line. A major advantage for patients who would otherwise need admission or complex outpatient IV setups.
What is the difference between Dalvance and oritavancin (Orbactiv/Kimyrsa)?
Both are long-acting lipoglycopeptides for ABSSSI. Oritavancin is truly single-dose. Dalvance uses a single-dose (1500 mg) or two-dose (1000 mg + 500 mg) regimen. Both are effective; choice is often by formulary.
How does Dalvance compare to daily vancomycin?
Both are bactericidal against MRSA. Vancomycin (generic) requires daily IV administration, typically via PICC, plus therapeutic drug monitoring. Dalvance’s single/two-dose regimen delivers a complete course without a PICC or repeated IV visits — a major convenience and cost-of-care advantage.
Should abscesses be drained even with Dalvance?
Yes — incision and drainage (I&D) is the primary treatment for abscesses, with antibiotics adjunctive. Dalvance is appropriate as an adjunct or for complicated ABSSSI where systemic antibiotic therapy is indicated. Don’t skip source control.
Take Control of Your Medication Costs
Long-acting single-dose antibiotic therapy avoids hospitalization — a significant patient and system benefit. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.